Company Overview: OXiGENE

Industry News

5 Aug

OXiGENE Reports Second Quarter 2015 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) — OXiGENE, Inc. (OXGN), a biopharmaceutical company developing novel therapies for treatment of cancer, today reported financial results for the quarter ended June 30, 2015. For the second quarter of 2015, OXiGENE reported a net loss of $3.3 million compared...

Read more

28 Jul

OXiGENE to Host Second Quarter Financial Results Conference Call and Webcast

OXiGENE, Inc. (OXGN), a biopharmaceutical company developing novel therapies for treatment of cancer, today announced that the company will report second quarter 2015 financial results and provide a business update on Tuesday, August 4, 2015. The company’s management team will host a conference call and webcast at 4:30 p.m....

Read more

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address